Table 2. Effects of enalapril and paricalcitol on serum sodium and potassium levels in diabetic rats.
| Sodium (mg/dl) |
% change |
Potassium (mg/dl) |
% change |
|
|---|---|---|---|---|
| Normal | 149.19 ± 0.38c | - | 4.90 ± 0.21b | - |
| Diabetic control | 154.55 ± 0.84a | 3.59 | 5.98 ± 0.26a | 22.04 |
| Diabetic treated with Enalapril | 150.27 ± 0.12bc | -2.76 | 5.16 ± 0.04b | -13.71 |
| Diabetic treated with Paricalcitol | 151.84 ± 0.35b | -1.75 | 5.23 ± 0.35b | -12.54 |
| Diabetic treated with Enalapril and Paricalcitol | 151.59 ± 0.74b | -1.91 | 4.83 ± 0.15b | -19.23 |
| F-probability | P<0.001 | P<0.05 | ||
| LSD at 5% level | 1.627 | 0.668 | ||
| LSD at 1% level | 2.202 | 0.904 | ||
- Data are expressed as mean ± SE. Number of detected samples in each group is six.
- Means, which share the same superscript symbol(s) are not significantly different.
- Percentage changes were calculated by comparing diabetic control group with normal control group and diabetic treated groups with diabetic control group.